Ruxolitinib attenuates microglial inflammatory response by inhibiting NF-κB/MAPK signaling pathway
Jingli Min, Hongmei Zheng, Heye Xia, Xuejun Tian, Meihao Liang, Jing Zhang, Wenhai Huang
Topics & Concepts
NeuroinflammationRuxolitinibMAPK/ERK pathwayMicrogliaPharmacologyJanus kinaseNF-κBTumor necrosis factor alphaProinflammatory cytokineCytokineMedicineSignal transductionInflammationImmunologyCancer researchBiologyCell biologyBone marrowMyelofibrosisNeuroinflammation and Neurodegeneration MechanismsImmune Response and InflammationInflammasome and immune disorders